E-LIB Suche - Ergebnisse für: Pen, Claude Le

1

Penetration rates of new pharmaceutical products in Europe:..:

Le Pen, Claude ; Bauduceau, Bernard ; Ansolabehere, Xavier...
Annales d'Endocrinologie. 82 (2021) 2 - p. 99-106 , 2021

Link: https://doi.org/10.1016/..

2

A health economic evaluation of needle-based confocal laser..:

Le Pen, Claude ; Palazzo, Laurent ; Napoléon, Bertrand
Endoscopy International Open. 5 (2017) 10 - p. E987-E995 , 2017

Link: https://doi.org/10.1055/..

3

Travel-Associated Rabies in Pets and Residual Rabies Risk, ..:

Ribadeau-Dumas, Florence ; Cliquet, Florence ; Gautret, Philippe...
Emerging Infectious Diseases. 22 (2016) 7 - p. 1268-1271 , 2016

Link: https://doi.org/10.3201/..

4

424 Confocal Laser Endomicroscopy (CLE): A Dominant Strateg..:

Pen, Claude Le ; Coron, Emmanuel ; Galmiche, Jean Paul
Gastroenterology. 148 (2015) 4 - p. S-92 , 2015

Link: https://doi.org/10.1016/..

5

Cost-effectiveness of rabies post-exposure prophylaxis in t..:

Ribadeau Dumas, Florence ; N'Diaye, Dieynaba S. ; Paireau, Juliette...
Vaccine. 33 (2015) 20 - p. 2367-2378 , 2015

Link: https://doi.org/10.1016/..

6

Public Health and Budget Impact of Probiotics on Common Res..:

Lenoir-Wijnkoop, Irene ; Gerlier, Laetitia ; Bresson, Jean-Louis...
PLOS ONE. 10 (2015) 4 - p. e0122765 , 2015

Link: https://doi.org/10.1371/..

7

Refocusing on R&D model or redefining marketing strategy? A..:

Barei, Fereshteh ; Le Pen, Claude
Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing. 14 (2014) 2-3 - p. 81-90 , 2014

Link: https://doi.org/10.1177/..

8

Biosimilar Versus Patented Erythropoietins: Learning from 5..:

Bocquet, François ; Paubel, Pascal ; Fusier, Isabelle...
Applied Health Economics and Health Policy. 13 (2014) 1 - p. 47-59 , 2014

Link: https://doi.org/10.1007/..

9

Biosimilar Granulocyte Colony-Stimulating Factor Uptakes in..:

Bocquet, François ; Paubel, Pascal ; Fusier, Isabelle...
Applied Health Economics and Health Policy. , 2014

Link: https://doi.org/10.1007/..

10

Temporary Authorization for Use: Does the French Patient Ac..:

Degrassat-Théas, Albane ; Paubel, Pascal ; Parent de Curzon, Olivier..
PharmacoEconomics. 31 (2013) 4 - p. 335-343 , 2013

Link: https://doi.org/10.1007/..

11

From generic to biosimilar drugs: why take an innovative pa..:

Barei, Fereshteh ; Le Pen, Claude ; Simoens, Steven
Farmeconomia. Health economics and therapeutic pathways. 13 (2012) 3S - p. 21-27 , 2012

Link: https://doi.org/10.7175/..

12

Cost Effectiveness of Rituximab Maintenance Therapy in Foll..:

Deconinck, Eric ; Miadi-Fargier, Houda ; Pen, Claude Le.
PharmacoEconomics. 28 (2010) 1 - p. 35-46 , 2010

Link: https://doi.org/10.2165/..

13

Is there a "continental" view of health economics evaluatio..:

Le Pen, Claude
The European Journal of Health Economics. 10 (2009) 2 - p. 121-123 , 2009

Link: https://doi.org/10.1007/..

14

Is There a "Continental" View of Health Economics Evaluatio..:

Le Pen, Claude
The European Journal of Health Economics. 10 (2009) 2 - p. 121-123 , 2009

Link: https://www.jstor.org/st..

15

« Patient » ou « personne malade » ? Les nouvelles figures ..:

Le Pen, Claude
Revue économique. 60 (2009) 2 - p. 257-271 , 2009

Link: https://www.jstor.org/st..